Article History
Received: 6 October 2020
Accepted: 13 October 2020
First Online: 30 October 2020
Compliance with ethical standards
:
: Giuseppe Curigliano has received personal fees from Ellipses Pharma, Roche, Pfizer, Novartis, Eli Lilly, Foundation Medicine, Bristol-Myers Squibb, Samsung and Daiichi Sankyo outside the submitted work. Aleix Prat has received personal fees from Roche, Pfizer, Novartis Daiichi Sankyo, AstraZeneca, Foundation Medicine, Bristol-Myers Squibb, Nanostring Technologies, Seattle Genetics and Guardant Health outside the submitted work. Paolo Tarantino declares that he has no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: No human participant was included in the study, thus no informed consent was required.